Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Gene Therapeutics & RNAiGenome-based Drug Discovery

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1780865

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1780865

Gene Editing

PUBLISHED:
PAGES: 383 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Gene Editing Market to Reach US$18.5 Billion by 2030

The global market for Gene Editing estimated at US$8.1 Billion in the year 2024, is expected to reach US$18.5 Billion by 2030, growing at a CAGR of 14.8% over the analysis period 2024-2030. CRISPR / CAS9 Technology, one of the segments analyzed in the report, is expected to record a 12.8% CAGR and reach US$6.9 Billion by the end of the analysis period. Growth in the Zinc Finger Nucleases Technology segment is estimated at 16.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.2 Billion While China is Forecast to Grow at 19.4% CAGR

The Gene Editing market in the U.S. is estimated at US$2.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.9 Billion by the year 2030 trailing a CAGR of 19.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.1% and 13.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.7% CAGR.

Global Gene Editing Market - Key Trends & Drivers Summarized

How Is Gene Editing Transforming Biotechnology and Medicine?

Gene editing has emerged as one of the most revolutionary advancements in biotechnology, enabling precise modifications to an organism's DNA to correct genetic defects, enhance traits, or combat diseases. Technologies such as CRISPR-Cas9, TALENs (Transcription Activator-Like Effector Nucleases), and ZFNs (Zinc Finger Nucleases) have drastically improved the efficiency and accuracy of genetic modifications, making gene editing more accessible for research, agriculture, and medical applications. This ability to make targeted changes at the DNA level has positioned gene editing at the forefront of personalized medicine, genetic disease therapy, and advanced biopharmaceutical development.

The growing demand for gene therapies and regenerative medicine has accelerated research and investment in gene editing. Diseases such as sickle cell anemia, cystic fibrosis, and certain types of cancers are being targeted for treatment using CRISPR-based therapies, with clinical trials demonstrating promising results. Beyond medicine, gene editing is also reshaping agriculture, allowing for the development of genetically modified crops with improved resistance to pests, drought, and diseases. Additionally, breakthroughs in synthetic biology have enabled researchers to engineer bacteria and yeast strains for sustainable biofuel and pharmaceutical production. As regulatory frameworks evolve and ethical considerations are addressed, gene editing is expected to become a critical tool for advancing health sciences and food security.

Which Industries Are Driving the Demand for Gene Editing Technologies?

The healthcare and pharmaceutical industries are at the forefront of gene editing applications, with increasing investments in gene therapy, precision medicine, and stem cell research. CRISPR-based therapies are being explored for treating rare genetic disorders, infectious diseases, and even age-related conditions. Biopharmaceutical companies are leveraging gene editing to develop next-generation biologics, including engineered T-cell therapies (CAR-T) for cancer treatment. Additionally, advancements in in vivo gene editing have paved the way for potential treatments that directly modify patient DNA without the need for ex vivo manipulation.

In agriculture, gene editing is revolutionizing crop improvement by enabling the precise alteration of plant genomes without introducing foreign DNA, making it distinct from traditional genetically modified organisms (GMOs). This has led to the development of climate-resilient crops with enhanced nutritional profiles, higher yields, and reduced reliance on chemical pesticides. Additionally, livestock breeding programs are incorporating gene editing to enhance disease resistance and improve productivity. The environmental sector is also exploring gene editing for bioremediation applications, such as engineering microorganisms to break down pollutants and reduce greenhouse gas emissions. As gene editing continues to expand its reach, demand across these diverse industries is expected to grow.

What Are the Latest Technological Advancements in Gene Editing?

Recent breakthroughs in gene editing technologies have significantly improved precision, efficiency, and scalability. CRISPR-based advancements, including base editing and prime editing, have enabled scientists to make precise DNA modifications without causing double-stranded breaks, reducing the risk of unintended mutations. These refined techniques are opening new possibilities for correcting genetic disorders at the molecular level with greater safety and accuracy. Additionally, the development of CRISPR-Cas variants with expanded targeting capabilities has broadened the range of editable genomic regions, further enhancing the versatility of gene editing tools.

Beyond CRISPR, synthetic biology and AI-powered gene prediction models are accelerating the discovery of novel gene editing targets. AI-driven algorithms are optimizing guide RNA designs, improving editing efficiency, and predicting potential off-target effects. Moreover, the integration of gene editing with single-cell sequencing technologies has enabled more detailed analysis of genetic modifications, leading to better control over gene expression and cellular behavior. These advancements are driving the next wave of innovation in biotechnology, unlocking new therapeutic opportunities and expanding gene editing applications beyond traditional boundaries.

What Factors Are Fueling the Growth of the Gene Editing Market?

The growth in the gene editing market is driven by several factors, including increasing investments in biotechnology research, rising demand for gene therapies, and technological advancements in genome engineering. Government initiatives and funding for genetic research have expanded, with agencies such as the National Institutes of Health (NIH) and private biotech firms committing substantial resources to gene editing innovation. The accelerating pace of clinical trials for CRISPR-based therapies has further validated the potential of gene editing in personalized medicine, prompting regulatory agencies to refine approval pathways for genetic interventions.

Additionally, the agriculture sector’s growing need for sustainable and resilient crops has boosted the adoption of gene editing technologies. As global food security concerns rise, precision breeding methods enabled by CRISPR and other gene editing tools are becoming increasingly important. The emergence of AI-driven gene editing platforms, enhanced bioinformatics tools, and machine learning applications has also contributed to market expansion by optimizing editing accuracy and efficiency. As ethical guidelines evolve and regulatory approvals streamline, gene editing is expected to become a key driver of scientific and medical advancements, shaping the future of healthcare, agriculture, and environmental sustainability.

SCOPE OF STUDY:

The report analyzes the Gene Editing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technology (CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology, Other Technologies); Application (Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application, Other Applications); End-User (Biotech & Pharma Companies End-User, Contract Research Organizations End-User, Research Institutes End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • Arcturus Therapeutics
  • Beam Therapeutics
  • Caribou Biosciences
  • Century Therapeutics
  • CRISPR Therapeutics
  • Editas Medicine
  • Horizon Discovery Limited
  • Inscripta
  • Integrated DNA Technologies
  • Intellia Therapeutics
  • Life Edit Therapeutics
  • Metagenomi
  • New England Biolabs
  • OriGene Technologies
  • Precision BioSciences
  • Prime Medicine
  • Regeneron Pharmaceuticals
  • Sangamo Therapeutics
  • Synthego
  • Ubigene Biosciences

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP31158

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Gene Editing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Breakthroughs in CRISPR and Base Editing Technologies Propel Gene Editing Into Mainstream Drug Discovery
    • Surging Investments in Cell and Gene Therapy Pipelines Drive Clinical Demand for Precise Gene Editing Tools
    • Rise in Rare Disease Research and Orphan Drug Development Strengthens Business Case for Targeted Editing Platforms
    • Strategic Collaborations Between Pharma and Biotech Fuel Innovation in In Vivo and Ex Vivo Editing Applications
    • Rapid Expansion of CAR-T, NK Cell, and Stem Cell Therapy Trials Accelerates Need for Efficient Gene Editing Systems
    • Advancements in Delivery Vectors, Including LNPs and Viral Platforms, Improve Editing Efficiency and Safety
    • Increased Regulatory Clarity and Framework Development Support Clinical Advancement of Gene Editing Therapies
    • Growing Consumer and Ethical Debate Over Germline Editing Creates Regulatory and Market Development Challenges
    • Global CRISPR Patent Licensing Agreements Shape Competitive Dynamics and Access to Editing Platforms
    • Emergence of Prime Editing and Epigenome Editing Technologies Expands Scope Beyond Knockout Models
    • Government Funding and National Innovation Programs Fuel Academic and Translational Research in Gene Editing
    • Adoption of Gene Editing in Agriculture and Livestock Opens Non-Therapeutic Market Opportunities
    • Demand for High-Throughput Screening Tools and Functional Genomics Platforms Spurs Use of Gene Editing in Drug Discovery
    • OEM Integration of AI and Automation Enhances Editing Precision, Efficiency, and Customization
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Gene Editing Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Gene Editing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Gene Editing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Gene Editing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for CRISPR / CAS9 Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for CRISPR / CAS9 Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for CRISPR / CAS9 Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Zinc Finger Nucleases Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Zinc Finger Nucleases Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Zinc Finger Nucleases Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Talens Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Talens Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Talens Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Contract Research Organizations End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Contract Research Organizations End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Contract Research Organizations End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Research Institutes End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Research Institutes End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Research Institutes End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Biotech & Pharma Companies End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Biotech & Pharma Companies End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Biotech & Pharma Companies End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Cell Line Engineering Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Cell Line Engineering Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Cell Line Engineering Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Animal Genetic Engineering Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Animal Genetic Engineering Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Animal Genetic Engineering Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Plant Genetic Engineering Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Plant Genetic Engineering Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Plant Genetic Engineering Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Gene Editing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Gene Editing by Technology - Percentage Breakdown of Value Sales for CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Gene Editing by End-user - Percentage Breakdown of Value Sales for Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Gene Editing by Application - Percentage Breakdown of Value Sales for Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Gene Editing by Technology - Percentage Breakdown of Value Sales for CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Gene Editing by End-user - Percentage Breakdown of Value Sales for Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Gene Editing by Application - Percentage Breakdown of Value Sales for Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Gene Editing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Gene Editing by Technology - Percentage Breakdown of Value Sales for CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Gene Editing by End-user - Percentage Breakdown of Value Sales for Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Gene Editing by Application - Percentage Breakdown of Value Sales for Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Gene Editing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Gene Editing by Technology - Percentage Breakdown of Value Sales for CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Gene Editing by End-user - Percentage Breakdown of Value Sales for Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Gene Editing by Application - Percentage Breakdown of Value Sales for Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Gene Editing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Gene Editing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Gene Editing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Gene Editing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Gene Editing by Technology - Percentage Breakdown of Value Sales for CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Gene Editing by End-user - Percentage Breakdown of Value Sales for Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Gene Editing by Application - Percentage Breakdown of Value Sales for Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Gene Editing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Gene Editing by Technology - Percentage Breakdown of Value Sales for CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Gene Editing by End-user - Percentage Breakdown of Value Sales for Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Gene Editing by Application - Percentage Breakdown of Value Sales for Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Gene Editing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Gene Editing by Technology - Percentage Breakdown of Value Sales for CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Gene Editing by End-user - Percentage Breakdown of Value Sales for Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Gene Editing by Application - Percentage Breakdown of Value Sales for Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Gene Editing by Technology - Percentage Breakdown of Value Sales for CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Gene Editing by End-user - Percentage Breakdown of Value Sales for Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Gene Editing by Application - Percentage Breakdown of Value Sales for Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Gene Editing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Gene Editing by Technology - Percentage Breakdown of Value Sales for CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Gene Editing by End-user - Percentage Breakdown of Value Sales for Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Gene Editing by Application - Percentage Breakdown of Value Sales for Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Gene Editing by Technology - Percentage Breakdown of Value Sales for CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Gene Editing by End-user - Percentage Breakdown of Value Sales for Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User for the Years 2015, 2025 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Spain 15-Year Perspective for Gene Editing by Application - Percentage Breakdown of Value Sales for Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Gene Editing by Technology - Percentage Breakdown of Value Sales for CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Gene Editing by End-user - Percentage Breakdown of Value Sales for Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User for the Years 2015, 2025 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Russia 15-Year Perspective for Gene Editing by Application - Percentage Breakdown of Value Sales for Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Gene Editing by Technology - Percentage Breakdown of Value Sales for CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Gene Editing by End-user - Percentage Breakdown of Value Sales for Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 15-Year Perspective for Gene Editing by Application - Percentage Breakdown of Value Sales for Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Gene Editing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Gene Editing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Gene Editing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Gene Editing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Gene Editing by Technology - Percentage Breakdown of Value Sales for CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Gene Editing by End-user - Percentage Breakdown of Value Sales for Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User for the Years 2015, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 15-Year Perspective for Gene Editing by Application - Percentage Breakdown of Value Sales for Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Gene Editing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Gene Editing by Technology - Percentage Breakdown of Value Sales for CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Gene Editing by End-user - Percentage Breakdown of Value Sales for Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User for the Years 2015, 2025 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Australia 15-Year Perspective for Gene Editing by Application - Percentage Breakdown of Value Sales for Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications for the Years 2015, 2025 & 2030
  • INDIA
    • Gene Editing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 170: India Recent Past, Current & Future Analysis for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Gene Editing by Technology - Percentage Breakdown of Value Sales for CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Gene Editing by End-user - Percentage Breakdown of Value Sales for Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User for the Years 2015, 2025 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: India 15-Year Perspective for Gene Editing by Application - Percentage Breakdown of Value Sales for Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Gene Editing by Technology - Percentage Breakdown of Value Sales for CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Gene Editing by End-user - Percentage Breakdown of Value Sales for Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User for the Years 2015, 2025 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: South Korea 15-Year Perspective for Gene Editing by Application - Percentage Breakdown of Value Sales for Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Gene Editing by Technology - Percentage Breakdown of Value Sales for CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Gene Editing by End-user - Percentage Breakdown of Value Sales for Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User for the Years 2015, 2025 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Gene Editing by Application - Percentage Breakdown of Value Sales for Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Gene Editing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Gene Editing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Gene Editing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Gene Editing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Gene Editing by Technology - Percentage Breakdown of Value Sales for CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Gene Editing by End-user - Percentage Breakdown of Value Sales for Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User for the Years 2015, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Latin America 15-Year Perspective for Gene Editing by Application - Percentage Breakdown of Value Sales for Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Gene Editing by Technology - Percentage Breakdown of Value Sales for CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Gene Editing by End-user - Percentage Breakdown of Value Sales for Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User for the Years 2015, 2025 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Argentina 15-Year Perspective for Gene Editing by Application - Percentage Breakdown of Value Sales for Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Gene Editing by Technology - Percentage Breakdown of Value Sales for CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Gene Editing by End-user - Percentage Breakdown of Value Sales for Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User for the Years 2015, 2025 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Brazil 15-Year Perspective for Gene Editing by Application - Percentage Breakdown of Value Sales for Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Gene Editing by Technology - Percentage Breakdown of Value Sales for CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Gene Editing by End-user - Percentage Breakdown of Value Sales for Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User for the Years 2015, 2025 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Mexico 15-Year Perspective for Gene Editing by Application - Percentage Breakdown of Value Sales for Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Gene Editing by Technology - Percentage Breakdown of Value Sales for CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Gene Editing by End-user - Percentage Breakdown of Value Sales for Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 15-Year Perspective for Gene Editing by Application - Percentage Breakdown of Value Sales for Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Gene Editing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Gene Editing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Gene Editing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Gene Editing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Gene Editing by Technology - Percentage Breakdown of Value Sales for CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Gene Editing by End-user - Percentage Breakdown of Value Sales for Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User for the Years 2015, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Middle East 15-Year Perspective for Gene Editing by Application - Percentage Breakdown of Value Sales for Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Gene Editing by Technology - Percentage Breakdown of Value Sales for CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Gene Editing by End-user - Percentage Breakdown of Value Sales for Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User for the Years 2015, 2025 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Iran 15-Year Perspective for Gene Editing by Application - Percentage Breakdown of Value Sales for Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Gene Editing by Technology - Percentage Breakdown of Value Sales for CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Gene Editing by End-user - Percentage Breakdown of Value Sales for Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User for the Years 2015, 2025 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Israel 15-Year Perspective for Gene Editing by Application - Percentage Breakdown of Value Sales for Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Gene Editing by Technology - Percentage Breakdown of Value Sales for CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Gene Editing by End-user - Percentage Breakdown of Value Sales for Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User for the Years 2015, 2025 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 15-Year Perspective for Gene Editing by Application - Percentage Breakdown of Value Sales for Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Gene Editing by Technology - Percentage Breakdown of Value Sales for CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Gene Editing by End-user - Percentage Breakdown of Value Sales for Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User for the Years 2015, 2025 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: UAE 15-Year Perspective for Gene Editing by Application - Percentage Breakdown of Value Sales for Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Gene Editing by Technology - Percentage Breakdown of Value Sales for CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Gene Editing by End-user - Percentage Breakdown of Value Sales for Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User for the Years 2015, 2025 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 15-Year Perspective for Gene Editing by Application - Percentage Breakdown of Value Sales for Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications for the Years 2015, 2025 & 2030
  • AFRICA
    • Gene Editing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Gene Editing by Technology - CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Gene Editing by Technology - Percentage Breakdown of Value Sales for CRISPR / CAS9 Technology, Zinc Finger Nucleases Technology, Talens Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Gene Editing by End-user - Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Gene Editing by End-user - Percentage Breakdown of Value Sales for Contract Research Organizations End-User, Research Institutes End-Users and Biotech & Pharma Companies End-User for the Years 2015, 2025 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Gene Editing by Application - Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 310: Africa 15-Year Perspective for Gene Editing by Application - Percentage Breakdown of Value Sales for Cell Line Engineering Application, Animal Genetic Engineering Application, Plant Genetic Engineering Application and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!